Checkpoint Therapeutics, Inc.
CKPT
Revenue
41.00k
▲35.00k▲583.33%
6 Months ChangeAssets
5.67M
▼-6.31M▼-52.65%
3 Months ChangeLiabilities
21.42M
▼-806.00k▼-3.63%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001410578-24-001317
2024-08-12
Form 8-K
ID: 0001104659-24-088117
2024-07-25
Form 8-K
ID: 0001104659-24-082631
2024-07-03
Form 8-K
ID: 0001104659-24-077593
2024-06-24
Form 8-K
ID: 0001104659-24-074148
2024-05-14
Form 8-K
ID: 0001104659-24-060882
2024-05-10
Form 10-Q
ID: 0001410578-24-000738
2024-05-10
Form 8-K
ID: 0001104659-24-059667
2024-03-22
Form 8-K
ID: 0001104659-24-037602
2024-03-18
Form 8-K
ID: 0001104659-24-035524